US equities
|
NVDA
$240.69
▲+0.75%
SPCX
$173.83
▲+1.60%
MU
$1,067.31
▲+0.32%
MRVL
$285.13
▲+5.12%
AMD
$655.88
▲+3.82%
SNDK
$1,676.08
▼-1.65%
AVGO
$378.74
▲+4.48%
INTC
$113.19
▼-2.58%
NVDA
$240.69
▲+0.75%
SPCX
$173.83
▲+1.60%
MU
$1,067.31
▲+0.32%
MRVL
$285.13
▲+5.12%
AMD
$655.88
▲+3.82%
SNDK
$1,676.08
▼-1.65%
AVGO
$378.74
▲+4.48%
INTC
$113.19
▼-2.58%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Lifecore Biomedical, Inc. - Common Stock
(NQ:
LFCR
)
6.480
-0.040 (-0.61%)
Delayed Quote
Updated: 12:34 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lifecore Biomedical, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 29, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024
Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
August 26, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
August 26, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
August 26, 2024
From
Kirby McInerney LLP
Via
Business Wire
Pending Lead Plaintiff Deadline in the LFCR Class Action: Robbins LLP Reminds Stockholders With Large Losses of Lifecore Biomedical, Inc. to Seek Counsel
August 23, 2024
From
Robbins LLP
Via
GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 22, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
August 21, 2024
From
Schall Law
Via
GlobeNewswire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
August 19, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Urges LFCR Stockholders to Contact the Firm for Information About the Lifecore Biomedical, Inc. Class Action
August 19, 2024
From
Robbins LLP
Via
GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
August 18, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 15, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
August 14, 2024
From
Schall Law
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
August 13, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
LFCR CLASS ACTION ALERT: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Lifecore Biomedical, Inc. Class Action
August 12, 2024
From
Robbins LLP
Via
GlobeNewswire
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
August 12, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
August 12, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024
↗
August 12, 2024
LFCR stock results show that Lifecore Biomedical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
August 09, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Poulin I Willey I Anastopoulo Announces A Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. (LFCR)
August 09, 2024
Poulin Willey Anastopoulo LLC announces that a class action has been filed in the United States District Court for the District of Minnesota on behalf of all persons and entities that purchased or...
From
Poulin | Willey | Anastopoulo, LLC
Via
GlobeNewswire
Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit
August 09, 2024
From
Robbins LLP
Via
Business Wire
LFCR CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
August 09, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
LFCR CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
August 09, 2024
NEW YORK, NY - (NewMediaWire) - August 09, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased Lifecore Biomedical Inc....
Via
TheNewswire.com
Topics
Lawsuit
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
August 09, 2024
From
Kirby McInerney LLP
Via
GlobeNewswire
LFCR SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
August 08, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
LFCR SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Lifecore Biomedical Inc. (LFCR) and Lead Plaintiff Deadline on September 27, 2024
August 08, 2024
NEW YORK, NY - (NewMediaWire) - August 08, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased Lifecore Biomedical Inc....
Via
TheNewswire.com
Topics
Lawsuit
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
August 08, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
